EGFR and diabetic kidney disease: Researchers have determined that phospholipase Cr1 interacts with activated EGFR and transactivates through PI3K-PKCβ1-AKT signaling in mesangial cells to mediate hyperglycemia-induced up-regulation of type I collagen, thereby affecting the development of diabetic nephropathy [47].